Therorna
Clinical trials sponsored by Therorna, explained in plain language.
-
Revolutionary In-Body CAR-T therapy targets autoimmune diseases
Disease control Recruiting nowThis early-phase study tests a new treatment called TI-0032-III for people with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard care. The treatment uses a special injection to create CAR-T cells inside the body, which then target and dest…
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Experimental vaccine targets HPV-16 tumors in early trial
Disease control Recruiting nowThis early-stage study is testing a new therapeutic vaccine called TI-0093 in 12 adults with HPV-16 positive cancers that have returned or spread. The vaccine is given as a series of five shots over about a month. The main goals are to check safety, find the best dose, and see if…
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC